Additionally, DDM cellular uptake was significantly decreased in normal cells, suggesting the CD44 and FR-α dependent uptake, which facilitated the enhanced intracellular drug concentration toward both CD44 and FR-α receptors which overexpressing in cancer cells. This evidence concerns the gene CD44 and cancer.